|
MUT expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62769797640294E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.99200722162641E-16 |
| Normal-vs-Stage2 |
2.15009999804394E-08 |
| Normal-vs-Stage3 |
6.37967456640354E-12 |
| Normal-vs-Stage4 |
9.17987907911311E-12 |
| Stage1-vs-Stage2 |
6.419600E-01 |
| Stage1-vs-Stage3 |
4.047800E-01 |
| Stage1-vs-Stage4 |
8.223900E-03 |
| Stage2-vs-Stage3 |
3.023800E-01 |
| Stage2-vs-Stage4 |
2.192100E-02 |
| Stage3-vs-Stage4 |
1.392760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.55431223447522E-15 |
| Normal-vs-AfricanAmerican |
2.60058641288197E-12 |
| Normal-vs-Asian |
1.5689000000263E-06 |
| Caucasian-vs-AfricanAmerican |
6.564400E-01 |
| Caucasian-vs-Asian |
5.826000E-01 |
| AfricanAmerican-vs-Asian |
5.435800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.55111512312578E-16 |
| Normal-vs-Female |
1.76879622060255E-11 |
| Male-vs-Female |
6.127600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.24975635080227E-14 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
1.2623235789988E-13 |
| Normal-vs-Extreme_Obese |
2.738300E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.507800E-01 |
| Normal_Weight-vs-Obese |
3.724600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.171970E-01 |
| Extreme_Weight-vs-Obese |
1.475350E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.871150E-01 |
| Obese-vs-Extreme_Obese |
2.593600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.55940000304378E-08 |
| Normal-vs-Age(41-60Yrs) |
1.62558855265615E-12 |
| Normal-vs-Age(61-80Yrs) |
1.66533453693773E-15 |
| Normal-vs-Age(81-100Yrs) |
1.49309999919467E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.900600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.552800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.724800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.742200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.037200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.736800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62525548574877E-12 |
| Normal-VS-Type2 PRCC |
3.7584046985728E-11 |
| Normal-VS-KIRP CIMP |
7.037200E-04 |
| Normal-VS-Unclassified PRCC |
2.40873987422674E-12 |
| Type1 PRCC-VS-Type2 PRCC |
2.186200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.807200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.659400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.108600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.474600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.512000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63891122895166E-12 |
| Normal-vs-N1 |
1.82427999999568E-05 |
| Normal-vs-N2 |
3.72959999550559E-08 |
| N0-vs-N1 |
6.466800E-01 |
| N0-vs-N2 |
1.667020E-01 |
| N1-vs-N2 |
2.428200E-01 |
|
|
